Form 4 for TNDM TANDEM DIABETES CARE INC
Accepted 2025-08-11 00:00:00 ET · period of report 2025-08-11 · accession 0001438133-25-000165 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-11 | 2025-08-11 | TNDM | Sheridan John F | Pres, CEO, Dir | P - Purchase | $10.23 | +10.0K | 106.3K | +10% | +$102.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-11 | P | A | 10,000 | $10.23 | 106,327 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $10.19 to $10.33 per share. The reported price reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |